top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Computational Approaches: Drug Discovery and Design in Medicinal Chemistry and Bioinformatics
Computational Approaches: Drug Discovery and Design in Medicinal Chemistry and Bioinformatics
Autore Tutone Marco
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (387 p.)
Soggetto topico Chemistry
Research & information: general
Soggetto non controllato 3CL-Pro
3D-QSAR
acetylcholinesterase
aging progression mechanism
Alzheimer's disease
aminophenylbenzamide
antibody:antigen interactions
antivirals
binding free energies
binding site
binding space
carbon nanotubes
cholesterol
computational biology
consensus models
COVID-19
COX-2 inhibitors
deep learning
diabetes
docking simulations
doxorubicin encapsulation
drug delivery system
drug discovery
drug repositioning
drug repositioning approaches
drug repurposing
drug resistance
drug-resistance mutations
dual mode of action
dual-target lead discovery
epitope binning
epitope mapping
epitope prediction
FimH
fingerprints
gene expression signature
genome-wide genetic and epigenetic network (GWGEN)
glycoprotein D (gD)
haeckelite defects
HDACs
hERG toxicity
herpes simplex virus fusion proteins
high-throughput virtual screening
HIV-2 protease
homology modeling
hTSPO
human dihydrofolate reductase
immunoproteasome
in silico
induced structural deformations
induced-fit docking
inhibitors
isoform-selective histone deacetylase inhibitors
isomeric space
ligand-based model
machine learning
main protease
MD binding
MD simulation
metadynamics
methotrexate
molecular docking
molecular dynamics
molecular dynamics (MD) simulation
molecular dynamics simulation
molecular dynamics simulations
molecular modeling
MRP4
multi-modal
multiple-molecule drug
multiprotein inhibiting natural compounds
multiscale
multitargeting
mutants
Mycobacterium tuberculosis
n/a
natural compounds
neurodegenerative disorders
nicotinic acetylcholine receptor
non-covalent inhibitors
noncovalent interactions
oxidative stress
PF-00835231
pharmacophore model
pharmacophore modeling
PK11195
polypharmacology
proteasome
protein docking
protein threading modeling
proteomic signature
RNA expression regulation
SARS-CoV-2
skin aging
SNPs
sodium-glucose co-transporters 2
Src inhibitors
Stone-Wales defects
structural bioinformatics
structural characterization
systems medicine design
tuberculosis
urinary tract infections
uropathogenic bacteria
variants
virtual screening
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Computational Approaches
Record Nr. UNINA-9910557519403321
Tutone Marco  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug Repositioning: Current Advances and Future Perspectives
Drug Repositioning: Current Advances and Future Perspectives
Autore Yuhei Nishimura
Pubbl/distr/stampa Frontiers Media SA, 2019
Descrizione fisica 1 online resource (153 p.)
Collana Frontiers Research Topics
Soggetto topico Pharmacology
Soggetto non controllato computational analysis
data sharing
database
Drug Repositioning
Integrative strategies
molecular docking
multi-omics
Patenting
polypharmacology
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Drug Repositioning
Record Nr. UNINA-9910346734903321
Yuhei Nishimura  
Frontiers Media SA, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Molecular Psychiatry
Molecular Psychiatry
Autore Rein Theo
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (288 p.)
Soggetto topico Medicine and Nursing
Mental health services
Soggetto non controllato (2R,6R)-Hydroxynorketamine
5-HT 4 receptor
5-HT4R
acid sphingomyelinase
actin dynamics
affective temperament
alcohol dependence
alpha-synuclein
Alzheimer's disease
antidepressant
antidepressant treatment
antidepressants
antipsychotics
basic-helix-loop-helix
BDNF
behavior
biomarker discovery
biomarkers
bipolar disorder
brain
cardiovascular disease
cell adhesion molecules
chemokines
childhood-onset schizophrenia (COS)
circadian rhythms
coactivator
cognition
copy number variation (CNV)
cordance
CRMP-2
CyP40
cytoskeleton
dendritic arborization
depression
DISC1
DNA methylation
dopaminergic gene polymorphisms
DRR1
drug design
early neurodevelopment
electroconvulsive therapy
endocrinology
expression
FAM107A
FKBP5
FKBP51
FKBP52
forced swimming
gender
gene expression
general cognitive function
genetic correlation
glucocorticoids
GR
GWAS
Hamilton Scale of Depression
hippocampus
HPA axis
Hsp90
Immune response
immunohistochemistry
immunology
induced pluripotent stem cell (iPSC)
inflammation
intelligence
Ketamine
liver enzymes
machine learning
major depression
major depressive disorder
mineralocorticoid receptor knockout
miRNAs
molecular chaperones
mood disorder
multi-target drugs
multi-task learning
n/a
nervous system
neurodevelopment
neuroinflammation
neuronal differentiation
obesity
Parkinson's disease
polypharmacology
PP5
PPARγ
proteomics
PSA-NCAM
psychiatric disease
psychiatry
rapid-acting
resilience
response variability
Roman rat lines
schizophrenia
serotonin
sex difference
sleep
sleep EEG
SNCA
social defeat
sphingolipid metabolism
steroid hormones
stress
stress physiology
stress response
susceptibility
synapse
T cells
Th17 cells
transcription biology
Treg cells
trkB
TU3A
western blot
withdrawal
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557793503321
Rein Theo  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Natural Compounds as New Cancer Treatments / Enrique Barrajon
Natural Compounds as New Cancer Treatments / Enrique Barrajon
Autore Barrajon Enrique
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (128 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato microbiota
treatment
sulforaphane
synergy
epigenetic
natural compound
xenohormesis
anticancer
miR-663
tyrosine kinase inhibitors
acetylation
epidemiology
double-blinded
inflammation
bladder cancer
polypharmacology
animal model
synbiotics
resveratrol
royal jelly
5-aza-2'-deoxycytine
saponins
phenolics
cardiovascular disease
antioxidant
colorectal cancer
trypsin inhibitors
seeds
green tea
Gac
randomized clinical trial
melanoma
adverse events
extraction
microbiome
Momordica cochinchinensis
freeze dried extract
renal cell carcinoma
methylation
cancer
probiotics
ISBN 9783039213665
3039213660
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367758003321
Barrajon Enrique  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui